Clinical Trials Sponsored by Nykode Therapeutics ASA
Total 87 results
-
Nykode Therapeutics ASAVaccibody ASCompleted
-
Nykode Therapeutics ASANektar Therapeutics; Vaccibody ASCompletedLocally Advanced or Metastatic Solid TumoursGermany
-
Nykode Therapeutics ASATheradex; Vaccibody ASCompletedHigh Grade Cervical Intraepithelial NeoplasiaGermany
-
Nykode Therapeutics ASAGenentech, Inc.; Vaccibody ASActive, not recruitingSolid Tumors, AdultSpain, United States, Germany
-
Nykode Therapeutics ASARoche Pharma AG; Vaccibody ASCompletedCervical Cancer | Cervix CancerBelgium, Germany, Bulgaria, Czechia, Norway, Poland
-
Nykode Therapeutics ASAMerck Sharp & Dohme LLCRecruitingHNSCC | HPV-Related Squamous Cell CarcinomaFrance, Norway, Spain, United Kingdom, Hungary, Poland, Czechia, Germany
-
Nykode Therapeutics ASARoche Pharma AG; GOG FoundationRecruitingCervical Cancer | HPV-Related Malignancy | HPV-Related Cervical CarcinomaUnited States
-
ASC TherapeuticsNot yet recruitingAcute-graft-versus-host Disease
-
Aspa TherapeuticsRecruitingCanavan DiseaseUnited States
-
Aspa TherapeuticsRecruiting
-
Orum Therapeutics USA, Inc.RecruitingHER2-positive Breast Cancer | HER-2 Gene Amplification | HER2 Gene Mutation | HER-2 Protein OverexpressionUnited States
-
Knight Therapeutics (USA) IncCompletedMucocutaneous LeishmaniasisBolivia
-
Knight Therapeutics (USA) IncCompletedMucocutaneous LeishmaniasisBolivia
-
Knight Therapeutics (USA) IncRecruitingLeishmaniasis or Other Uses of MiltefosineUnited States
-
Knight Therapeutics (USA) IncCompletedCutaneous Leishmaniasis | Mucosal LeishmaniasisUnited States
-
Knight Therapeutics (USA) IncWithdrawnLeishmaniasisUnited States
-
Ryvu Therapeutics SANot yet recruitingMyelofibrosisItaly, Poland
-
Ryvu Therapeutics SARecruitingAcute Myeloid LeukemiaItaly, Poland
-
Ryvu Therapeutics SAActive, not recruitingAcute Myeloid Leukemia | High-risk Myelodysplastic SyndromeUnited States, Poland
-
Cerenis Therapeutics, SATerminatedFamilial HypoalphalipoproteinemiaFrance, United States, Belgium, Canada, Israel, Italy, Netherlands
-
Cerenis Therapeutics, SACompletedHomozygous Familial HypercholesterolemiaUnited States, Canada, Italy, Netherlands, United Kingdom
-
Cerenis Therapeutics, SACompletedAcute Coronary SyndromeCanada, United States, France, Netherlands
-
Ryvu Therapeutics SARecruitingAdvanced Solid TumorSpain, Poland
-
EXACT Therapeutics ASRecruitingColorectal Cancer | Solid TumorUnited Kingdom, Norway
-
Cerenis Therapeutics, SACompleted
-
SeneXta Therapeutics SACompleted
-
Horizon Therapeutics USA, Inc.CompletedThyroid Eye Disease | Chronic (Inactive) Thyroid Eye DiseaseUnited States
-
Horizon Therapeutics USA, Inc.CompletedThyroid Eye DiseaseUnited States
-
Horizon Therapeutics USA, Inc.TerminatedDiffuse Cutaneous Systemic SclerosisUnited States
-
Asia Cell Therapeutics (Shanghai) Co., Ltd.Not yet recruitingDecompensated Liver Cirrhosis
-
Calliditas Therapeutics Suisse SAActive, not recruitingSquamous Cell Carcinoma of Head and NeckSpain, France, United States, Germany, Italy, Poland, United Kingdom
-
Asia Cell Therapeutics (Shanghai) Co., Ltd.Not yet recruitingAcute Respiratory Distress Syndrome
-
iTeos Belgium SARecruitingMetastatic NSCLC | Stage III NSCLCUnited States, Belgium, Spain, Switzerland, Italy, France, Canada, Poland, Czechia
-
Repare TherapeuticsDebiopharm International SARecruitingAdvanced Solid TumorUnited States, Canada, Denmark
-
Hubro Therapeutics ASQuotient SciencesCompleted
-
iTeos Belgium SACompleted
-
Asia Cell Therapeutics (Shanghai) Co., Ltd.RenJi HospitalNot yet recruiting
-
Ottawa Hospital Research InstituteKnight Therapeutics (USA) IncRecruiting
-
iTeos Belgium SAGlaxoSmithKline; iTeos TherapeuticsRecruitingMelanoma | Head and Neck Cancer | Lung Cancer | Advanced CancerSpain, Italy, France, United States, United Kingdom, Belgium
-
QED Therapeutics, Inc.Helsinn Healthcare SATerminatedFGFR2 Gene Mutation | Advanced CholangiocarcinomaKorea, Republic of, United States, Belgium, Spain, Taiwan, China, United Kingdom, France, Canada, Germany, Thailand, Italy, Portugal, Australia, Puerto Rico
-
QED Therapeutics, Inc.Helsinn Healthcare SATerminatedUpper Tract Urothelial Carcinomas | Urothelial Bladder CancerUnited States, France, Canada, Spain, Italy, Belgium, Germany, Netherlands, United Kingdom, Bulgaria, Greece
-
Repurposed Therapeutics, Inc.National Aeronautics and Space Administration (NASA)RecruitingMotion Sickness | Sea Sickness | Motion Sickness, SpaceUnited States
-
Repurposed Therapeutics, Inc.National Aeronautics and Space Administration (NASA)RecruitingMotion Sickness, Space | Motion Simulation | Parabolic FlightUnited States
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsCompletedSevere COVID-19Israel
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsCompletedDifferential Thyroid CancerUnited States
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsCompletedActive Plaque PsoriasisUnited States, Germany, Israel
-
Rhizen Pharmaceuticals SAIncozen Therapeutics Pvt LtdCompleted
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsCompletedSingle-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma MultiformeGlioblastoma MultiformeIsrael, United States
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsCompletedGlioblastomaUnited States, Israel, Canada